Last reviewed · How we verify
NCT03694314
Effect of Omega-3 Fatty Acids on Sleep and Behavior (Pilot Study)
NA trial testing Omega-3 fatty acids in Disturbances in Initiating and Maintaining Sleep in 29 participants. Completed in 30 June 2019.
30 June 2019
Quick facts
| Lead sponsor | University of Pennsylvania |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 29 |
| Start date | 15 May 2018 |
| Primary completion | 30 June 2019 |
| Estimated completion | 30 June 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Omega-3 fatty acids — full drug profile →
- Placebo
Conditions studied
- Disturbances in Initiating and Maintaining Sleep — all drugs for Disturbances in Initiating and Maintaining Sleep →
- Behavior Problem — all drugs for Behavior Problem →
Sponsor
University of Pennsylvania
Who can join
Adults 5 to 9, any sex, with Disturbances in Initiating and Maintaining Sleep or Behavior Problem. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this feasibility study is to determine whether a nutritional intervention in children and their parents can improve their sleep quality and behavior. The study is a randomized, double-blind, placebo-controlled parallel trial of omega-3 supplementation to children and their mothers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03694314
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Omega-3 fatty acids
Trials testing the same drug.
- NCT07363551 — Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression · NA · recruiting
- NCT04485871 — Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids · NA · recruiting
- NCT03994055 — Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer · NA · completed
- NCT05972798 — Exploration of the Potential Mechanisms of n-3 Fatty Acids Supplementation in Depression and Cognitive Function in Patie · NA · completed
- NCT03510715 — An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia · Phase 3 · completed
Other University of Pennsylvania trials
Trials by the same sponsor.
- NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
- NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
- NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
- NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
- NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03694314 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
- Last refreshed: 8 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03694314.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing